Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sapropterin on Cognitive Abilities in Young Adults With Phenylketonuria
NCT01977820Phase 2Terminated
- Sponsor
- BioMarin Pharmaceutical
- Start
- Feb 2014
- Primary completion
- Nov 2014
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of sapropterin in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Feb 2014; status: terminated.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT01977820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01977820.